JAMUNARANI VEERARAGHAVAN

Concepts (184)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptor, ErbB-2
13
2025
514
3.030
Why?
Breast Neoplasms
22
2025
2498
2.800
Why?
Drug Resistance, Neoplasm
8
2025
717
1.330
Why?
Trastuzumab
9
2025
134
1.040
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2023
1214
0.960
Why?
Radiation-Sensitizing Agents
4
2011
25
0.850
Why?
Antineoplastic Agents, Immunological
1
2025
111
0.850
Why?
NF-kappa B
6
2011
455
0.840
Why?
Curcumin
3
2011
41
0.800
Why?
Gene Expression Regulation, Neoplastic
9
2021
1893
0.760
Why?
Azadirachta
2
2011
2
0.750
Why?
Signal Transduction
16
2025
4501
0.740
Why?
Plant Extracts
2
2011
119
0.670
Why?
Estrogen Receptor alpha
4
2021
468
0.620
Why?
Neuroblastoma
4
2011
520
0.620
Why?
Apoptosis
6
2019
1789
0.610
Why?
Neoadjuvant Therapy
6
2023
337
0.570
Why?
Antineoplastic Agents
4
2021
1660
0.560
Why?
Gamma Rays
3
2011
49
0.540
Why?
Gene Fusion
1
2016
55
0.510
Why?
Biomarkers, Tumor
7
2023
1484
0.510
Why?
Radiation, Ionizing
2
2011
41
0.450
Why?
Cell Line, Tumor
15
2025
3337
0.430
Why?
Carrier Proteins
2
2020
1022
0.430
Why?
Gene Rearrangement
1
2014
320
0.400
Why?
Rosaceae
1
2011
1
0.380
Why?
Molecular Targeted Therapy
4
2025
354
0.380
Why?
Protein Kinase Inhibitors
3
2025
529
0.380
Why?
Transcription Factor RelA
1
2011
53
0.370
Why?
Class I Phosphatidylinositol 3-Kinases
2
2023
74
0.360
Why?
Quinazolines
3
2023
174
0.360
Why?
Antineoplastic Agents, Phytogenic
1
2011
99
0.360
Why?
Superoxide Dismutase
2
2010
137
0.360
Why?
Mice, Nude
5
2025
707
0.350
Why?
Digestive System
1
2010
60
0.350
Why?
Genes, p53
1
2010
212
0.330
Why?
Sarcoma, Ewing
1
2010
107
0.320
Why?
Receptors, Estrogen
5
2021
797
0.320
Why?
Gene Expression Profiling
5
2021
1702
0.320
Why?
Gene Amplification
3
2019
228
0.310
Why?
Oncogene Proteins, Fusion
2
2020
209
0.300
Why?
Genomics
1
2016
1500
0.300
Why?
Tumor Necrosis Factor-alpha
1
2011
681
0.300
Why?
Tumor Microenvironment
2
2025
555
0.290
Why?
Phosphatidylinositol 3-Kinases
2
2019
337
0.260
Why?
Female
22
2025
66482
0.260
Why?
Pancreatic Neoplasms
1
2011
691
0.240
Why?
Protein Kinases
2
2016
332
0.230
Why?
Humans
29
2025
124593
0.230
Why?
Neoplasm Transplantation
3
2016
374
0.230
Why?
Extracellular Matrix Proteins
1
2025
154
0.230
Why?
Dose-Response Relationship, Radiation
3
2011
64
0.200
Why?
Cell Survival
4
2021
806
0.200
Why?
Receptors, G-Protein-Coupled
1
2025
292
0.200
Why?
Prognosis
5
2021
4625
0.200
Why?
Mice
10
2025
17630
0.200
Why?
Carcinogenesis
1
2025
331
0.190
Why?
Remission Induction
2
2020
299
0.190
Why?
Brain Neoplasms
1
2011
1207
0.190
Why?
Linear Energy Transfer
2
2011
7
0.190
Why?
Plant Leaves
2
2011
43
0.180
Why?
Cyclin-Dependent Kinase 6
1
2021
41
0.180
Why?
Cyclin-Dependent Kinase 4
1
2021
58
0.180
Why?
Pyrimidinones
1
2020
40
0.170
Why?
Xenograft Model Antitumor Assays
4
2021
882
0.170
Why?
Pyridones
1
2020
110
0.170
Why?
Mevalonic Acid
1
2019
19
0.160
Why?
Protein-Tyrosine Kinases
1
2020
209
0.160
Why?
Pyridines
1
2021
229
0.160
Why?
Antineoplastic Agents, Hormonal
1
2021
256
0.160
Why?
Piperazines
1
2021
236
0.160
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
113
0.160
Why?
Cinnamates
1
2018
15
0.160
Why?
Brain
1
2010
2983
0.150
Why?
Neoplasms, Hormone-Dependent
1
2018
100
0.150
Why?
Animals
10
2025
34072
0.150
Why?
Lymphocytes
1
2019
406
0.140
Why?
Indoles
1
2018
179
0.140
Why?
Oncogene Addiction
1
2017
3
0.140
Why?
In Situ Hybridization, Fluorescence
1
2019
762
0.140
Why?
Precision Medicine
1
2019
319
0.130
Why?
RNA-Binding Proteins
1
2020
573
0.130
Why?
Transcription, Genetic
3
2011
1697
0.130
Why?
RNA, Small Interfering
2
2016
660
0.130
Why?
Gene Expression
1
2020
1561
0.120
Why?
Genomic Instability
1
2016
228
0.120
Why?
Tumor Cells, Cultured
2
2021
1062
0.120
Why?
Proto-Oncogene Proteins c-akt
1
2017
486
0.120
Why?
Cell Proliferation
3
2018
2285
0.110
Why?
Ki-67 Antigen
1
2014
113
0.110
Why?
Open Reading Frames
1
2014
211
0.110
Why?
Cell Separation
1
2014
227
0.110
Why?
Radiation Tolerance
2
2011
48
0.110
Why?
Dose-Response Relationship, Drug
2
2021
1689
0.110
Why?
Follow-Up Studies
2
2019
5145
0.100
Why?
Intercellular Signaling Peptides and Proteins
1
2014
279
0.100
Why?
Neoplasm Invasiveness
1
2014
617
0.100
Why?
Treatment Outcome
3
2023
12322
0.100
Why?
DNA-Binding Proteins
1
2020
2043
0.100
Why?
Proto-Oncogene Proteins c-rel
1
2011
3
0.100
Why?
Flow Cytometry
1
2014
797
0.100
Why?
Aniline Compounds
1
2011
18
0.100
Why?
Aminoquinolines
1
2011
35
0.100
Why?
NF-kappa B p50 Subunit
1
2011
13
0.100
Why?
NF-KappaB Inhibitor alpha
1
2011
36
0.100
Why?
Sequence Analysis, RNA
1
2014
371
0.100
Why?
I-kappa B Proteins
1
2011
41
0.090
Why?
Neoplasm Staging
3
2020
1248
0.090
Why?
Time Factors
2
2011
6292
0.090
Why?
Adaptor Proteins, Signal Transducing
1
2014
541
0.090
Why?
High-Throughput Nucleotide Sequencing
1
2016
882
0.090
Why?
Cell Movement
1
2014
836
0.090
Why?
Infrared Rays
1
2010
23
0.090
Why?
bcl-2-Associated X Protein
1
2010
71
0.090
Why?
ErbB Receptors
1
2011
281
0.090
Why?
Sequence Analysis, DNA
1
2016
1758
0.080
Why?
Fruit
1
2011
219
0.080
Why?
Telomerase
1
2011
160
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
1
2010
173
0.080
Why?
DNA Primers
1
2010
657
0.080
Why?
Transfection
1
2011
1061
0.080
Why?
Transcriptional Activation
1
2010
484
0.080
Why?
Phenotype
2
2016
4256
0.070
Why?
Tamoxifen
2
2020
363
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
1284
0.070
Why?
RNA, Messenger
2
2011
2816
0.070
Why?
MCF-7 Cells
2
2018
222
0.070
Why?
Polymerase Chain Reaction
1
2010
1586
0.070
Why?
Combined Modality Therapy
1
2010
1231
0.070
Why?
Carcinoma, Squamous Cell
1
2011
666
0.070
Why?
Phosphorylation
2
2021
1615
0.060
Why?
Base Sequence
1
2010
3090
0.060
Why?
DNA
1
2011
1597
0.060
Why?
Genetic Predisposition to Disease
1
2016
3153
0.060
Why?
Models, Biological
1
2010
1459
0.060
Why?
Oxidative Stress
1
2010
802
0.060
Why?
Laminin
1
2025
69
0.060
Why?
Antibodies, Monoclonal, Humanized
2
2020
505
0.060
Why?
Cytokines
1
2009
1290
0.050
Why?
Adenocarcinoma
1
2009
1022
0.050
Why?
Mutation
2
2017
5825
0.050
Why?
Mice, Inbred C57BL
1
2010
4406
0.050
Why?
Up-Regulation
2
2016
862
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2020
85
0.040
Why?
Datasets as Topic
1
2020
89
0.040
Why?
Dasatinib
1
2020
40
0.040
Why?
src-Family Kinases
1
2020
89
0.040
Why?
Clinical Trials, Phase II as Topic
1
2020
71
0.040
Why?
Clinical Trials, Phase III as Topic
1
2020
68
0.040
Why?
Gene Knockdown Techniques
1
2020
355
0.040
Why?
Breast
1
2020
214
0.040
Why?
MAP Kinase Signaling System
1
2020
310
0.040
Why?
Radiation Dosage
2
2009
135
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
165
0.040
Why?
Chemotherapy, Adjuvant
1
2019
361
0.040
Why?
Heterografts
1
2018
171
0.040
Why?
G2 Phase Cell Cycle Checkpoints
1
2016
6
0.030
Why?
Estradiol
1
2018
535
0.030
Why?
Estrogens
1
2018
513
0.030
Why?
Survival Analysis
1
2020
1496
0.030
Why?
Gene Silencing
1
2016
235
0.030
Why?
Middle Aged
3
2020
26714
0.030
Why?
Drug Design
1
2016
147
0.030
Why?
Cell Cycle
1
2016
610
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2016
1016
0.030
Why?
DNA Damage
1
2016
513
0.030
Why?
Reproducibility of Results
1
2020
2876
0.030
Why?
I-kappa B Kinase
1
2011
61
0.020
Why?
Aged
2
2020
19703
0.020
Why?
Cell Death
1
2011
240
0.020
Why?
DNA, Neoplasm
1
2011
301
0.020
Why?
Disease Models, Animal
1
2021
4350
0.020
Why?
Genome, Human
1
2016
1273
0.020
Why?
Algorithms
1
2016
1619
0.020
Why?
Baculoviral IAP Repeat-Containing 3 Protein
1
2009
5
0.020
Why?
X-Linked Inhibitor of Apoptosis Protein
1
2009
9
0.020
Why?
Inhibitor of Apoptosis Proteins
1
2009
46
0.020
Why?
Adult
2
2020
29438
0.020
Why?
Aged, 80 and over
1
2019
6533
0.020
Why?
Microtubule-Associated Proteins
1
2009
244
0.020
Why?
Neoplasm Proteins
1
2011
669
0.020
Why?
Promoter Regions, Genetic
1
2011
1327
0.020
Why?
Ubiquitin-Protein Ligases
1
2009
358
0.020
Why?
Young Adult
1
2019
9014
0.020
Why?
VEERARAGHAVAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (184)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_